Key statistics

Is CORZ a good stock to buy in 2026?

Core Scientific (CORZ) presents a mixed picture for investors. While analysts show strong conviction with 86.4% Buy ratings and a significant +34.1% upside to their $31.6 target, its current valuation metrics like the negative P/E of -6.26x (compared to a sector average of 36.5x) and a deeply negative DCF fair value of $-4.71 (-120.0%) suggest extreme caution. Therefore, assessing if CORZ is a good stock requires a deeper look into its unique business model and future prospects, given these contrasting financial signals.

2026 CORZ price scenarios

Based on analyst consensus of $31.6 from 22 analysts. Not a prediction by Alert Invest.

About Core Scientific, Inc. (CORZ)

Core Scientific, Inc. operates facilities for digital asset mining and colocation services in North America. It provides blockchain infrastructure, software solutions, and services.

The company, under CEO Adam Sullivan, operates with a considerable workforce, positioning it as a key player in the digital asset mining and colocation space. Its distinctive strengths lie in its large-scale operational capacity and ability to adapt to the evolving blockchain infrastructure demands, offering essential services to the growing cryptocurrency ecosystem.

CORZ competitive moat and business analysis

Core Scientific, Inc. operates within the highly competitive Software – Infrastructure sector, yet its financial metrics reveal significant challenges. With a net margin of -342.93%, the company faces substantial profitability hurdles. The ROE and ROIC data are not available (N/A), which makes a direct assessment of capital efficiency difficult. Typically, a strong competitive moat would be reflected in robust margins and high returns on capital, which are currently absent for CORZ stock.

The company’s revenue streams primarily stem from its core activities: digital asset mining and providing colocation services as indicated by the segment data `[(‘symbol’, ‘CORZ’), (‘fiscalYear’, 2024), (‘period’, ‘FY’), (‘reportedCurrency’, ‘USD’), (‘date’, ‘2024-12-31’)]`. Geographic revenue breakdown is not available (`Geo: []`), which limits understanding of its global market penetration or regional dependencies. The business model is deeply intertwined with the fluctuating nature of digital asset values and mining difficulty.

Considering a revenue growth of -37.5%, the trend for CORZ indicates a period of contraction. Without a transcript quote available, it’s challenging to ascertain specific management insights into the declining revenue. This trend suggests that the company is either undergoing significant restructuring, facing strong headwinds in its core markets, or struggling to maintain its market position against competitors. Investors should carefully monitor future earnings calls for explanations and strategic adjustments to understand how Core Scientific plans to reverse this trend and build a sustainable moat.

To truly gauge the competitive landscape for CORZ, it is essential to compare its performance against peers in the Technology sector. Investors might look at companies like CORZ vs BLSH, CORZ vs CFLT, and CORZ vs DBX to understand relative strengths in areas such as operational efficiency, market share, and technological innovation. Such comparisons can shed light on whether CORZ’s current challenges are systemic to the industry or specific to its operational execution.

Core Scientific, Inc. analyst rating

Based on 22 analysts. 86.4% rate CORZ Buy or Strong Buy.

An 86.4% Buy rating from 22 analysts for CORZ stock is indeed a strong endorsement, particularly within the dynamic Technology sector, suggesting a high level of confidence in the company’s future prospects among professionals. This consensus highlights a belief that, despite current financial metrics, Core Scientific has significant upside potential according to the analyst community.

Is CORZ undervalued or overvalued?

When evaluating CORZ valuation, a key metric to consider is its P/E ratio, which stands at -6.26x. This is a significant discount compared to the Software – Infrastructure sector average of 36.5x. While a negative P/E often indicates unprofitability, for high-growth or transitioning companies, it points to current losses rather than inherent cheapness. However, this vast difference suggests that CORZ stock is either severely undervalued by this metric if future profitability is expected, or analysts are looking beyond traditional earnings for their positive outlook.

Another crucial aspect of CORZ valuation is its Discounted Cash Flow (DCF) fair value, which is calculated at $-4.71, indicating that the stock is currently -120.0% overvalued relative to this intrinsic valuation model. This stark contrast between a positive analyst consensus and a negative DCF suggests a considerable divergence in valuation perspectives. Investors should exercise caution and conduct thorough due diligence, as a negative DCF value implies that the company’s future cash flows do not justify its current price. The P/S ratio of 21.12x also points to a relatively expensive valuation based on sales, further complicating the picture of whether CORZ is a good stock to invest in based on traditional metrics.

CORZ financial health & key metrics

For value investors considering CORZ stock, the financial health presents a challenging profile. While the negative P/E ratio and P/B ratio might superficially appear ‘cheap’, they primarily reflect the company’s current unprofitability. The significant revenue decline of -37.5% year-over-year, coupled with a deeply negative net margin of -342.93% and a weak free cash flow yield of -6.29%, raises concerns about operational efficiency and sustainable growth. Furthermore, a DCF fair value of $-4.71 suggests that based on future cash flow projections, the current CORZ valuation is significantly inflated, making it difficult to justify as a value play despite the attractive analyst consensus.

Core Scientific, Inc. earnings history & next report

Core Scientific, Inc. reported EPS of $-0.1, missing estimates by 400.0%. Next earnings: 2026-08-14 with EPS estimate of $-0.02339.

With Core Scientific, Inc. having missed its previous EPS estimates by a substantial 400.0% (reporting $-0.1), the upcoming earnings report on 2026-08-14 will be critical. Investors should closely watch for improvements in profitability metrics, particularly the net margin and free cash flow, as the company aims for an EPS estimate of $-0.02339. Key areas to scrutinize will include revenue stability, operational efficiency, and any updates regarding its digital asset mining and colocation strategy that could impact future CORZ stock performance.

CORZ daily short volume

Short volume data from FINRA CNMS Consolidated — shares sold short in the most recent US trading session. A high short ratio can signal bearish conviction or a potential short squeeze. Updated every trading day.

CORZ insider trading activity

Corporate insiders must report trades to the SEC within two business days.

Source: SEC Form 4 via EDGAR · Data: Financial Modeling Prep · Not investment advice

Recent CORZ analyst rating changes

Core Scientific, Inc. stock news today

How does CORZ compare to its peers?

For investors seeking to diversify their portfolio or explore similar opportunities within the Technology sector, particularly Software – Infrastructure, understanding how CORZ stock stacks up against its competitors is essential. These peers offer alternative investment profiles and business models within the same broad industry.

FAQ — Core Scientific, Inc. (CORZ) stock